Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine crossover study in capsaicin-induced neuropathic pain
2011-003933-32Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ivabradine in Neuralgia (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Heat threshold measured by quantitative sensory testing. Started Sep 2011; status: completed.
02
Drugs
ivabradine
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2011-003933-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003933-32.